Doses - TRIAMCINOLONE ACETONIDE

Dogs:

For glucocorticoid effects:
a) 0.25 - 2 mg PO once daily for 7 days; 0.11 - 0.22 mg/kg IM or SQ. (Kirk 1989)
b) 0.11 - 0.22 mg/kg PO, IM or SQ once daily. (Jenkins 1985)
c) For tablets: 0.11 mg/kg PO initially once a day, may increase to 0.22 mg/kg PO oncedaily if initial response is unsatisfactory. As soon as possible, but not later than 2 weeks, reduce dose gradually to 0.028 - 0.055 mg/kg/day. (Booth 1988), (Package insert;
Vetalog® Tablets¯Solvay)
d) For injectable product: 0.11 - 0.22 mg/kg for inflammatory or allergic disorders, and0.22 mg/kg for dermatological disorders. Effects generally persist for 7-15 days; ifsymptoms recur, may repeat or institute oral therapy.
For intralesional injection: Usual dose is 1.2 - 1.8 mg; inject around lesion at 0.5 - 2.5cm intervals. Do not exceed 0.6 mg at any one site or 6 mg total dose. May repeat asnecessary. (Package insert; Vetalog® Injection¯Solvay)
e) As an antiinflammatory agent: 0.05 mg/kg PO bid-tid (Morgan 1988)

Cats:

For glucocorticoid effects:
a) 0.25 - 0.5 mg PO once daily for 7 days. (Kirk 1989)
b) 0.11 - 0.22 mg/kg PO, IM or SQ once daily. Maximum of 0.5 mg. (Jenkins 1985)
c) For tablets: 0.11 mg/kg PO initially once a day, may increase to 0.22 mg/kg PO oncedaily if initial response is unsatisfactory. As soon as possible, but not later than 2 weeks, reduce dose gradually to 0.028 - 0.055 mg/kg/day. (Booth 1988), (Package insert;
Vetalog® Tablets¯Solvay)
d) For injectable product: 0.11 - 0.22 mg/kg for inflammatory or allergic disorders, and0.22 mg/kg for dermatological disorders. Effects generally persist for 7-15 days; ifsymptoms recur, may repeat or institute oral therapy.
For intralesional injection: Usual dose is 1.2 - 1.8 mg; inject around lesion at 0.5 - 2.5cm intervals. Do not exceed 0.6 mg at any one site or 6 mg total dose. May repeat asnecessary. (Package insert; Vetalog® Injection¯Solvay)
For feline plasma cell gingivitis-pharyngitis:
a) 2 - 4 mg PO once a day to every other day. (DeNovo, Potter, and Woolfson 1988)
For feline polymyopathy:
a) 0.5 - 1.0 mg/kg PO once a day. (Knaack 1988)

Cattle:

For glucocorticoid effects:
a) 0.02 - 0.04 mg/kg IM; 6 - 18 mg intra-articularly. (Howard 1986)

Horses:

For glucocorticoid effects:
a) 0.1 - 0.2 mg/kg IM or SQ; 3 - 6 mg subconjunctivally. (Robinson 1987)
b) 0.011 - 0.022 mg/kg PO bid;0.011 - 0.022 mg/kg IM or SQ;6 - 18 mg intra-articularly or intrasynovially, may repeat after 3-4 days; (Package inserts; Vetalog® Powder and Injection¯Solvay)
Dosage Forms/Preparations/Approval Status/Withdrawal Times - All require a prescription (Rx).
Veterinary-Approved Products: Note: marketing status of oral preparations is in question.
Triamcinolone Tablets 0.5 mg, 1.5 mg; Vetalog® Tablets (Fort Dodge), generic. Approved foruse in dogs and cats
Triamcinolone Acetonide Oral Powder 15 gram packets containing 10 grams of triamcinoloneacetonide.; Vetalog® Oral Powder (Fort Dodge). Approved for use in horses.
Triamcinolone acetonide suspension for injection 2 mg/ml; 6 mg/ml ; Vetalog® Parenteral
Veterinary (Fort Dodge); Generic. (Rx). Approved for use in dogs, cats, and horses.
Human-Approved Products include:
Triamcinolone Tablets 1 mg, 2 mg, 4 mg, 8 mg; Aristocort® (Fujisawa); Generic (Rx)
Triamcinolone Oral Syrup 4 mg/5ml Kenacort® (Apothecon); (Rx)
Triamcinolone Acetonide Sterile Suspension for injection 3 mg/ml, 10 mg/ml, 40 mg/ml; manytradenames; Generic, (Rx)
Many topical preparations are available, alone and in combination with other agents and inhaledproducts are also approved.